Level Ventures
74 posts

Level Ventures
@LevelVC
The capital partner to outlier managers and entrepreneurs.




Really excited to launch our fund 4! techcrunch.com/2025/09/23/tim…


I asked Albert at @LevelVC why consensus investing has the most alpha: "At the end of the day, you need to be where capital is going. Capital flows drive everything. You want to position yourself in front of where capital flows are going. And you want to do it in a way where you get paid for the risk. You can't pay prices that are too high. You really want to be first to the new consensus. And benefit from the follow-on flows. This is the highest form of alpha. We call this Criticality Investing. One way to think about it, new startups need to solve problems. And there are problems that are not yet in the capital rotation. But they're going to be. Another way to think about it, there's the first-order effects, like the AI platforms. Then there's the second order, where if something is true, you think about the next thing (this might be MCP severs). And then there's a third order after that. And you want to figure out where the consensus will be in the second and third orders before everyone else. So I'm not saying you just want to be non-consensus. That alone doesn't make much sense. Especially as capital is concentrating more and more in the winners. What matters most is positioning yourself to where capital will be flowing."

How we built a unicorn from seed in 5 years… There are no secrets, but purpose, pace, and an incredible team certainly help. “We’re combining ancient ancestral wisdom with the power of nature’s chemistry with modern AI and drug discovery,” Colluru said. “We’re standing on the shoulders of maybe the giant, which is Mother Nature.” Read more by @damiangarde in @business about how we raised our Series D, advanced our lead candidate in atopic dermatitis to Phase 1b, and brought on a pharma legend Mikael Dolsten as we prepare to enter more programs in the clinic this year... and stay tuned for more. #Unicorn #Startups #AI #DrugDiscovery #Nature







